Linked Data API

Show Search Form

Search Results

1602606
star this property human indexable true more like this
star this property published true more like this
star this property registered interest false more like this
star this property answer date less than 2023-03-22more like thismore than 2023-03-22
star this property date less than 2023-03-08more like thismore than 2023-03-08
star this property date tabled less than 2023-03-08more like thismore than 2023-03-08
star this property ddp created less than 2023-03-08T21:40:53.810Zmore like thismore than 2023-03-08T21:40:53.810Z
star this property answering body
Department of Health and Social Care more like this
star this property question status Tabled more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property ddp modified
remove filter
less than 2023-03-23T12:06:16.071Zmore like thismore than 2023-03-23T12:06:16.071Z
star this property hansard heading Voluntary Scheme for Branded Medicines Pricing and Access more like this
star this property house id 2 more like this
star this property identifier HL6287 more like this
star this property legislature
25277
star this property parliament number 58 more like this
star this property question first answered
less than 2023-03-23T11:34:32.487Zmore like thismore than 2023-03-23T11:34:32.487Z
star this property question text To ask His Majesty's Government what assessment they have made of the findings of the report by The Association of the British Pharmaceutical Industry False economy? How NHS medicine procurement threatens the UK’s Life Sciences growth engine, published on 23 February, that the continued current high rebate rates under the voluntary and statutory schemes for branded medicines during the next five years would mean foregoing £50 billion in GDP and £17.9 billion in tax revenues as a result of lost research and development investment; and what are their estimates of the value of the potential lost investment in this sector. more like this
star this property session
2022/23 more like this
star this property session number 3 more like this
star this property tabling member printed
Lord Warner more like this
star this property title House of Lords Tabled Parliamentary Question 2022/23 HL6287 more like this
unstar this property type
WrittenParliamentaryQuestion
star this property uin HL6287 more like this
star this property version 2 more like this
star this property written parliamentary question type Ordinary more like this
star this property answer answer
star this property creator
1732
star this property label Biography information for Lord Warner more like this
star this property publisher 25277
star this property tabling member
1732
star this property label Biography information for Lord Warner more like this